Direct In Vivo Activation of T Cells with Nanosized Immunofilaments Inhibits Tumor Growth and Metastasis

[Image: see text] Adoptive T cell therapy has successfully been implemented for the treatment of cancer. Nevertheless, ex vivo expansion of T cells by artificial antigen-presenting cells (aAPCs) remains cumbersome and can compromise T cell functionality, thereby limiting their therapeutic potential....

Descripción completa

Detalles Bibliográficos
Autores principales: Weiss, Lea, Weiden, Jorieke, Dölen, Yusuf, Grad, Emilia M., van Dinther, Eric A. W., Schluck, Marjolein, Eggermont, Loek J., van Mierlo, Guido, Gileadi, Uzi, Bartoló-Ibars, Ariadna, Raavé, René, Gorris, Mark A. J., Maassen, Lisa, Verrijp, Kiek, Valente, Michael, Deplancke, Bart, Verdoes, Martijn, Benitez-Ribas, Daniel, Heskamp, Sandra, van Spriel, Annemiek B., Figdor, Carl G., Hammink, Roel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339791/
https://www.ncbi.nlm.nih.gov/pubmed/37338806
http://dx.doi.org/10.1021/acsnano.2c11884

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339791/
https://www.ncbi.nlm.nih.gov/pubmed/37338806
http://dx.doi.org/10.1021/acsnano.2c11884

Ejemplares similares